CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
26 hedge funds and large institutions have $12.4M invested in Cymabay Therapeutics in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
26
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$109K | |
| 2 | +$52K | |
| 3 | +$30.1K | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$28K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$27.9K |
Top Sellers
| 1 | -$1.36M | |
| 2 | -$1.14M | |
| 3 | -$323K | |
| 4 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
-$97.9K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$91K |